DK1291429T3 - Glutamin-fruktose-6-fosfat-amidotransferase-splice-variant og dets ekspressionsprodukt - Google Patents

Glutamin-fruktose-6-fosfat-amidotransferase-splice-variant og dets ekspressionsprodukt

Info

Publication number
DK1291429T3
DK1291429T3 DK01938602T DK01938602T DK1291429T3 DK 1291429 T3 DK1291429 T3 DK 1291429T3 DK 01938602 T DK01938602 T DK 01938602T DK 01938602 T DK01938602 T DK 01938602T DK 1291429 T3 DK1291429 T3 DK 1291429T3
Authority
DK
Denmark
Prior art keywords
gene
expression product
amino acid
protein
fructose
Prior art date
Application number
DK01938602T
Other languages
Danish (da)
English (en)
Inventor
Yasuchika Yamamoto
Takashi Okamoto
Tsutomu Fujiwara
Masashi Niimi
Hiroyuki Kyushiki
Atsunori Ueyama
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Application granted granted Critical
Publication of DK1291429T3 publication Critical patent/DK1291429T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1096—Transferases (2.) transferring nitrogenous groups (2.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK01938602T 2000-06-13 2001-06-12 Glutamin-fruktose-6-fosfat-amidotransferase-splice-variant og dets ekspressionsprodukt DK1291429T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000176631 2000-06-13
JP2000290679A JP4601143B2 (ja) 2000-06-13 2000-09-25 新規酵素遺伝子およびその発現産物
PCT/JP2001/004941 WO2001096574A1 (en) 2000-06-13 2001-06-12 Novel enzyme gene and its expression product

Publications (1)

Publication Number Publication Date
DK1291429T3 true DK1291429T3 (da) 2009-01-19

Family

ID=26593812

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01938602T DK1291429T3 (da) 2000-06-13 2001-06-12 Glutamin-fruktose-6-fosfat-amidotransferase-splice-variant og dets ekspressionsprodukt

Country Status (15)

Country Link
US (1) US7091018B2 (cg-RX-API-DMAC7.html)
EP (1) EP1291429B1 (cg-RX-API-DMAC7.html)
JP (1) JP4601143B2 (cg-RX-API-DMAC7.html)
KR (1) KR100882407B1 (cg-RX-API-DMAC7.html)
CN (1) CN100390286C (cg-RX-API-DMAC7.html)
AR (1) AR029130A1 (cg-RX-API-DMAC7.html)
AT (1) ATE407212T1 (cg-RX-API-DMAC7.html)
AU (2) AU2001264245B2 (cg-RX-API-DMAC7.html)
CA (1) CA2412880C (cg-RX-API-DMAC7.html)
DE (1) DE60135650D1 (cg-RX-API-DMAC7.html)
DK (1) DK1291429T3 (cg-RX-API-DMAC7.html)
ES (1) ES2312442T3 (cg-RX-API-DMAC7.html)
PT (1) PT1291429E (cg-RX-API-DMAC7.html)
TW (1) TWI232883B (cg-RX-API-DMAC7.html)
WO (1) WO2001096574A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006262364A1 (en) * 2005-06-20 2007-01-04 Exelixis, Inc. GFATs as modifiers of the Axin pathway and methods of use
US8106256B2 (en) * 2005-10-05 2012-01-31 Bayer Cropscience Ag Methods and means for producing hyaluronan
BRPI0713331A2 (pt) * 2006-06-30 2012-03-13 Hokkaido System Science Co., Ltd. composição para a transfecção de ácido nucléico
CN103301447B (zh) * 2013-06-25 2014-12-31 哈尔滨医科大学 DNA-PKcs在制备改变肿瘤细胞对MTX耐药性的药物中的应用
CN112980914A (zh) * 2019-12-12 2021-06-18 中国科学院大连化学物理研究所 Gfpt1基因作为靶点在筛选抗肿瘤药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993021330A1 (en) * 1992-04-22 1993-10-28 Zymogenetics, Inc. Human glutamine:fructose-6-phosphate amino-transferase
JPH1018683A (ja) * 1996-06-29 1998-01-20 Tesco Joho Center:Kk 吊下扉のレール装置
US5876713A (en) * 1996-08-13 1999-03-02 Takeda Chemical Industries Ltd Glutamine: fructose-6-phosphate amidotransferase, its production and use
JP4175680B2 (ja) * 1996-08-13 2008-11-05 武田薬品工業株式会社 新規タンパク質およびそのdna
WO2000037617A1 (en) * 1998-12-22 2000-06-29 G.D. Searle & Co. Glutamine: fructose-6-phosphate aminotransferase ii enzyme and their encoding nucleic acids

Also Published As

Publication number Publication date
EP1291429A4 (en) 2004-05-26
EP1291429A1 (en) 2003-03-12
PT1291429E (pt) 2008-12-15
JP4601143B2 (ja) 2010-12-22
ATE407212T1 (de) 2008-09-15
CA2412880C (en) 2010-05-04
ES2312442T3 (es) 2009-03-01
CA2412880A1 (en) 2002-12-13
US20040132020A1 (en) 2004-07-08
WO2001096574A1 (en) 2001-12-20
DE60135650D1 (de) 2008-10-16
TWI232883B (en) 2005-05-21
KR20030011868A (ko) 2003-02-11
CN1436239A (zh) 2003-08-13
JP2002065284A (ja) 2002-03-05
US7091018B2 (en) 2006-08-15
KR100882407B1 (ko) 2009-02-05
CN100390286C (zh) 2008-05-28
EP1291429B1 (en) 2008-09-03
AU2001264245B2 (en) 2006-04-27
AU6424501A (en) 2001-12-24
AR029130A1 (es) 2003-06-04

Similar Documents

Publication Publication Date Title
RU2468080C2 (ru) Новый класс терапевтических белковых молекул
KR960700340A (ko) 안정한 살균/투과성-증가 단백질 생성물 및 그를 포함하는 제약학적 조성물(stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same)
DE69531889D1 (de) Biologisch aktive Fragmente des Glucagon ähnlichen, insulinotropen Peptides
JP2002206000A5 (cg-RX-API-DMAC7.html)
ATE64619T1 (de) Menschliches apolipoprotein a1 sowie dessen variante, exprimiert in escherichia coli.
DE3587407D1 (de) Toxin-segment des kristallgens vom bacillus thuringiensis.
WO2001092497A3 (en) Human pancreatic islet glucose-6-phosphatase
DE60135650D1 (de) Amidotransferase und dessen expressionsprodukt
EP1279744A3 (en) Identification and use of molecules implicated in pain
EP1284297A3 (en) Identification and use of molecules implicated in pain
DE60127113D1 (de) Gd3 mimetische peptide
ATE501256T1 (de) Rekombinantes protein mit krebsunterdrückender wirkung, sein codierendes gen und seine verwendung
ATE490324T1 (de) Nukleinsäuren kodierend für polypeptide mit chips aktivität
DE69925116D1 (de) Neue, physiologisch aktive peptide und ihre verwendung.
SE8801723D0 (sv) Fibronectin binding protein as well as its preparation
RU97104072A (ru) Модуляторы веса тела, соответствующие нуклеиновые кислоты и протеины, а также их применение для диагностических и терапевтических целей
WO2003018829A3 (en) 6299, a human zinc carboxypeptidase family member and uses therefor
WO2002088378A3 (en) 66784, a novel human potassium channel and uses therefor
WO2006063800A8 (en) Cloning of honey bee allergen
ATE444362T1 (de) Onkogen, davon abgeleitetes rekombinantes protein und dessen verwendung
DE60036676D1 (de) G-protein-gekoppelter rezeptor-ähnliche proteine
EP1679372A4 (en) NEW PLEXIN POLYPEPTIDE, THIS CODING DNA AND USE THEREOF
EP1568775A4 (en) CANCER ASSOCIATED GEN
JP2002335976A5 (cg-RX-API-DMAC7.html)
WO2003029465A1 (fr) Gene hepnadc